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839FO-6 The Impact of Sirolimus-Eluting Stsnts in Diabetics: 
Results From the SIRIUS Trial 
lesion is waived, Pts have a 9 fold increased nsk for major adverse cardiac events during 
the following year despite a FFR 2 0.75. However, whether FFR based therapy stratifica- 
tion in these patients requires other cut off values is subject to further investigations. 
Martin B. Leon, David R. Holmes, Charles Simonton, Jeffrey W. Moses, Charles 
Q’Shaughnessy, Ronald P. Caputo, Shing C. Wang, Maurice Buchbinder, Greg 
Chapman, Richard E. Kuntz, Cardiovascular Research Foundation, New Y&k, NY 
1149-188 The Importance of Intravascular Ultrasound in 
Percutaneous Coronary Intervention for Small Coronary 
Arteries 
Background: Diabetics after coronary stent implantation manifest more frequent major 
adverse cardiac events (MACE) and increased restenosis @es). However, the effects of 
sirolimus-eluting stents @ES) in diabetics is poorly understood. 
Methods: In the randomized double-blind SIRIUS trial (1058 patients), which compared 
SES vs. control bare stents (CS). 26.4% of patients were diabetic. Within the diabetic 
subgroup (279 patients), lesion length was 14.5mm and reference vessel diameter was 
2.75mm. 
Kunihiro Matsushita, Haruo Hirayama, Mamoru Nanasato, Nagoya Daini Red Cross 
Hospital Cardiovascular Center, Nagoya, Japan 
Results: Follow-up angiography (8 6 months) and MACE (up to 9 months) were com- 
pared in the SES vs. CS diabetic subgroups (see table). Similar to the overall SIRIUS 
cohort, diabetics had greater Res and target lesion revascularization (TLR) in the small 
and medium size vessels (tercile analysis) and a disproportionate contribution to Res 
withm the proximal peri-stem region (46% in SES vs. 27% in CS). Among the diabetics, 
patients on insulin (n=62), demonstrated reduced angiographic and clinical benefit after 
SES therapy. 
Conclusions: Analysis of the diabetic SIRIUS patients indicates: (1) preserved SES rel- 
ative treatment effect on Res and TLR, despite higher absolute values; (2) clustering of 
Res and TLR events in the smaller vessels, due to relatively higher proximal peri-stent 
late loss; (3) reduced SES efficacy in diabetics on insulin therapy. Further improvement 
in SES results in diabetics may require increased stent coverage of peri-stent regions 
(esp. proximal). 
Follow-up parameter SES (n=l31) CS (n=l46) pvalue 
Late loss (mm): in-stent 0.29 1.20 <O.OOl 
Late loss (mm): in-lesion 0.40 1.00 <O.OOl 
Res (%): in-stem 6.3 46.5 <0.001 
Res (%): in-lesion 17.6 50.5 <O.OOl 
TLR (%) 7.2 22.9 <O.OOl 
MACE (%) 9.2 25.0 <0.001 
Background: Angioplasty of lesions in small coronary arteries remains a significant prob- 
lem because of the increased risk of restenosis. While we usually use quantitative coro- 
nary angiography (QCA) to define small coronary arteries, previous studies reported that 
QCA for small coronary arteries was not accurate. We studied the difference of resteno- 
sis rate between truly small coronary arteries (groupl) and falsely small coronary arteries 
(group2) divided by intravascuar ultrasound(lVUS). 
Methods: We studied 102 lesions whose reference diameter (RD) were less than 2.6 mm 
by QCA. These lesions were divided into 2 subgroups according to lumen diameter (LD) 
by IVUS (group 1: LD 2.5mm). The difference of restenosis rate was evaluated after 6 
months follow-up. 
Results: Baseline clinical and angiographlc characteristics were similar in the two groups. 
According to IVUS, 43 cases (42.2%) were defined as falsely small coronary arteries (LD 
> 2.5mm). RD by QCA are similar in two groups(2.31+0.04 vs 2.42kO.04, p=ns, respec- 
tnely). The rate of stenting was not significantly different (66.4% YS 95.3%, p=ns, respec- 
twely). Post-procedural lumen diameter was significantly larger in falsely small coronary 
arteries group (2.34+0.07 vs 2.71+0.09, p<O.OOl). The angiographic restenosis rate was 
44.1% in truly small coronary arteries group, and 20.9% in falsely small coronary arteries 
group (P<O.O5). 
Conclusion: Some small coronary arteries defined by QCA have LD more than 2.5mm by 
IVUS. In these lesions, the restenosis rate was almost similar with lesions more than 3.0 
mm. To discuss proper procedures for small coronary arteries, we should define small 
coronary arteries by IVUS. 
1149-189 Chronic Kidney Disease: The Silent Killer After 
Coronary Angioplasty 
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1149-187 Deferring of Patients With Rsstsnotic Coronary Lesions 
Based on the Concept of Fractional Flow Reserve 
Measurement 
Background: There is evidence that chronic kidney disease (CKD) is associated with 
increased mortality in patients undergoing PCI. The impact of CKD on quality of life 
(QOL) in PCI patients is unknown. 
Methods: We analyzed a prospective PCI regisby where CKD was categorized by crea- 
tinine clearance (CrCl) as mild (61-90 mllmin), moderate (31-60 mllmin) and severe (15- 
30 mllmin) and compared to those with normal CrCI. Patients with CrCl < 15 m!lmin or on 
hemodialysis were excluded. The Seattle Angina Questionnaire (SAQ) was administered 
at the time of the procedure and at 1 year. Mortality data was obtained from the National 
Death Index. Univariate and multivariate regression analyses were used. 
Results: 1,324 patients with CKD and 232 patients with normal renal function were stud- 
ied.There was more physical limitation in those with moderate and severe CKD but no 
difference in angina frequency or QOL at baseline. One-year mortality was 20.3, 5.9, 3.3 
and 1.7% for the severe, moderate, mild CKD, and normal renal function patients respec- 
tively (p < 0.001). By logistic regression analysis, severe CKD was the strongest inde- 
pendent predictor of death (Table). 
Johannes Rieber, lsabelle Erhard, Tobias Segmiller, Andreas Koenig, Thomas M. 
Schiele, Hagen Gross, Silke Ebel, Karl Theisen, Volker Klauss, Medizinische Klmik, 
University of Munich, Munich, Germany 
lntracoronary pressure measurement is a promising mettiod to invasively quantify the 
hemodynamic relevance of intermediate coronary lesions. Patients with coronary single 
vessel-disease and a Fractional Flow Reserve (FFR) > 0.75 across a de-nova coronary 
. lesion have a very low incidence for developing a maGr adverse cardiac event (MACE) 
during a follow-up of 24 months and should therefor not receive an intervention. How- 
ever, it is still unclear if this is also true in restenotic coronary lesions. The aim of the 
present study was to Investigate whether deferring of patients based on the measure- 
ment of FFR is also a safe option in restenotic lesions. 
Methods: 59 consecutive patients (Pt) (mean age S%lO ys) with stenoses of angio- 
graphically questionable relevance and a FFR > 0.75 were Included into the study. Based 
on the FFR measurement PTCA was avoided in all 47 patients with de-nova lesions (DL) 
. and 12 patients with restenotic lesions (RL). Patients were closely monitored on an out- 
patient basis. Primary endpoint was the occurance of major adverse cardiac events 
(rePTCA, CABG, myocardial infarction. death). Secondary endpoints were the time to 
revascularization procedures if performed during the follow-up as well as the change in 
angina status. 
Results: Mean follow-up was 492 * 252 days. The coronary risk profile as well as patient 
characteristics were similar in both groups. During first year 4 major adverse cardiac 
events occured ([DL] PTCA n=l; [RL] PTCA n=3). The risk for the development of major 
adverse clinical events during the first year was 2% in the DL-group and 16% in the RL- 
group (OR 9,0 p-=0,05). Time to revascularization procedures was 175 days (DL) and 
202265 days (RL). However, no significant change ln angina status was observed. 
Conclusion : FFR can accurately Identify patients at low risk for the development of 
major adverse cardiac events in de-nova lesions. If an intended PTCA in a restenotic 
OR for Death (95% Cl) Change QOL 
*P<o.ool P=NS 
Severe CKD 8.6 (2.2-33.5) * 33+/-28 
Moderate CKD 3.0 (0.9-10) 31+/-24 
Mild CKD 2.2 (0.7-7.7) 30+/-26 
At follow-up, there was no difference in the angina frequency, physical limitations or QOL 
among those with and without CKD. 
Conclusions: CKD is the most powerful independent predictor of mortality in PCI 
patients. These data suggest CKD signals a unique state of vascular pathobiology that is 
silent in terms of QOL measures, but lethal in terms of ultimate outcome. 
1149-190 Deceptive Ostial Coronary Lesions: Lack of 
Relationship Between Imaging and Physiology 
Ali Ziaee Sanjeev Puri, Steven C. Herrmann, Saad Bitar, Frank Bleyer, Souheil -I 
Khoukaz, Morton J. Kern, St. Louis University, St. Louis, MO 
Background: Estimation of ostial lesion severity by angiography has significant limita- 
tions due to angulation, branch overlap and artifact. To compare angiography and physi- 
ology, ostial diameter stenosis was compared to fractional flow resewe (FFR) in 31 
consecutive patients with 38 lesions 2 50% diameter narrowing. 
Methods: FFR was obtained with a 0.014” pressure guidewire and intracoronary ade- 
nosine (30-50 mcg). Two independent obsewers determined angiographic severity. 
Patients were divided into two groups by the degree of stenosis (270% stenosis and 50- 
70% stenosis). 
Results: The ostial lesions assessed were left main (n=5), anterior descending (n=6), 
diagonal (n=3), circumflex (n=7). marginal (n=3), right (n=6), posterior descending (n=3), 
and internal mammary (n=2). For _z 70% stenosis, FFR was 0.65 _+ .09; for ostial lesions 
between 50-70%, FFR was 0.91 + 0.03. In 18 ostial lesions with ) 70% stenosis, FFR 
was 20.75 in 15 and FFR co.75 in 3. All 20 ostial lesions with angiographic stenosis 
between 50.70% had FFR 2 0.75 (Yate’s p=O.O006, see table) 
